Clinical features and preventive therapies of radiation-induced xerostomia in head and neck cancer patient: a literature review
Open Access
- 15 August 2017
- journal article
- review article
- Published by Springer Nature in Applied Cancer Research
- Vol. 37 (1) , 1-8
Abstract
No abstract availableKeywords
This publication has 57 references indexed in Scilit:
- Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trialThe Lancet Oncology, 2011
- Stem cells and the repair of radiation‐induced salivary gland damageOral Diseases, 2010
- A systematic review of salivary gland hypofunction and xerostomia induced by cancer therapies: management strategies and economic impactSupportive Care in Cancer, 2010
- Randomized phase 2 study of concomitant chemoradiotherapy using weekly carboplatin/paclitaxel with or without daily subcutaneous amifostine in patients with locally advanced head and neck cancerCancer, 2009
- A new, simple maxillary‐sparing tongue depressor for external mandibular radiotherapy: A case reportHead & Neck, 2009
- Rescue of Salivary Gland Function after Stem Cell Transplantation in Irradiated GlandsPLOS ONE, 2008
- The influence of xerostomia after radiotherapy on quality of lifeSupportive Care in Cancer, 2007
- A randomized phase III prospective trial of bethanechol to prevent radiotherapy-induced salivary gland damage in patients with head and neck cancerOral Oncology, 2007
- Upfront submandibular salivary gland transfer in pharyngeal cancersOral Oncology, 2004
- Oral Sequelae of Head and Neck RadiotherapyCritical Reviews in Oral Biology & Medicine, 2003